Distinct Gut Microbiota and Arachidonic Acid Metabolism in Obesity-Prone and Obesity-Resistant Mice with a High-Fat Diet

Huixia Zhang,Shiqi Chen,Liu Yang,Shuai Zhang,Linqian Qin,Haiyang Jiang

DOI: https://doi.org/10.3390/nu16111579

IF: 5.9

2024-05-24

Nutrients

Abstract:An imbalance of energy intake and expenditure is commonly considered as the fundamental cause of obesity. However, individual variations in susceptibility to obesity do indeed exist in both humans and animals, even among those with the same living environments and dietary intakes. To further explore the potential influencing factors of these individual variations, male C57BL/6J mice were used for the development of obesity-prone and obesity-resistant mice models and were fed high-fat diets for 16 weeks. Compared to the obesity-prone mice, the obesity-resistant group showed a lower body weight, liver weight, adipose accumulation and pro-inflammatory cytokine levels. 16S rRNA sequencing, which was conducted for fecal microbiota analysis, found that the fecal microbiome's structural composition and biodiversity had changed in the two groups. The genera Allobaculumbiota, SMB53, Desulfovibrio and Clostridium increased in the obesity-prone mice, and the genera Streptococcus, Odoribacter and Leuconostoc were enriched in the obesity-resistant mice. Using widely targeted metabolomics analysis, 166 differential metabolites were found, especially those products involved in arachidonic acid (AA) metabolism, which were significantly reduced in the obesity-resistant mice. Moreover, KEGG pathway analysis exhibited that AA metabolism was the most enriched pathway. Significantly altered bacteria and obesity-related parameters, as well as AA metabolites, exhibited strong correlations. Overall, the phenotypes of the obesity-prone and obesity-resistant mice were linked to gut microbiota and AA metabolism, providing new insight for developing an in-depth understanding of the driving force of obesity resistance and a scientific reference for the targeted prevention and treatment of obesity.

nutrition & dietetics

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore the different characteristics of gut microbiota and arachidonic acid metabolism in obesity - prone (HFD - P) and obesity - resistant (HFD - R) mice under high - fat diet conditions and their influence on obesity susceptibility. Specifically, by establishing HFD - P and HFD - R mouse models and using 16S rRNA sequencing and widely - targeted metabolomics analysis methods, the researchers explored the following points:

1. **Differences in gut microbiota**: The study compared the structural composition and diversity of the gut microbiota in HFD - P and HFD - R mice and found that there were significant differences in the gut microbiota between the two groups of mice. For example, in HFD - P mice, the genera such as Allobaculum, SMB53, Desulfovibrio and Clostridium increased, while in HFD - R mice, the genera such as Streptococcus, Odoribacter and Leuconostoc were enriched.

2. **Differences in metabolomics**: Through widely - targeted metabolomics analysis, the study found 166 differential metabolites, especially the products related to arachidonic acid (AA) metabolism were significantly reduced in HFD - R mice. KEGG pathway analysis showed that AA metabolism was the most enriched pathway.

3. **Correlation analysis**: The study also carried out a correlation analysis among significantly changed bacteria, obesity - related parameters and AA metabolites, and found that there was a strong correlation among these factors.

Overall, this study aims to deeply understand the role of gut microbiota and arachidonic acid metabolism in obesity susceptibility and provide a scientific basis for the prevention and treatment of obesity.